H.M. Knol - Concepedia

Author

H.M. Knol

University Medical Center Groningen

Also Known As

H M Knol, H Marieke Knol, H. Knol, H. M. KNOL, H. M. Knol, H. Marieke Knol, H.M. KNOL, H.M. Knol, Hendrika M Knol

Publications

468

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen

About

H.M. Knol is an author at University Medical Center Groningen specializing in obstetrics, medicine, and women's health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	163
2	Obstetrics	5	5	163
3	Public Health	2	2	71
4	Emergency Medicine	1	1	11
5	Family Medicine	1	1	16

H.M. Knol

Publications

307

Citations

H-Index

Page 1

	Year	Citations
Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease Eva M. de Wee, H.M. Knol, Evelien P. Mauser‐Bunschoten, Thrombosis and Haemostasis	2011	92
The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynecologic abnormalities H.M. Knol, André B. Mulder, D.H. Bogchelman, American Journal of Obstetrics and Gynecology GynecologyMenstrual HealthGynecologic AbnormalitiesMenstrual CycleBleeding Disorder	2013	61
The risk of postpartum hemorrhage in women using high dose of low-molecular-weight heparins during pregnancy H.M. Knol, L. Schultinge, Nic J.G.M. Veeger, Thrombosis Research Postpartum HemorrhageHigh DoseMaternal ComplicationGynecologyPregnancy	2012	55
Cumulative pregnancy rates after sequential treatment with modified natural cycle IVF followed by IVF with controlled ovarian stimulation M.J. Pelinck, H.M. Knol, N.E.A. Vogel, Human Reproduction	2008	40
No increased systemic fibrinolysis in women with heavy menstrual bleeding S. Wiewel‐Verschueren, H.M. Knol, Ton Lisman, Journal of Thrombosis and Haemostasis Increased Systemic FibrinolysisThrombosisUterine FibroidsGynecologyHemostasis	2014	20
Reproductive choices and obstetrical experience in Dutch carriers of haemophilia A and B H.M. Knol, M. A. J. VOSKUILEN, F. HOLTERMAN, Haemophilia Family MedicineBleeding ComplicationsFertilityReproductive HealthGynecology	2010	16
Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial Larissa I. van der Windt, Job Klumper, Ruben G. Duijnhoven, The Lancet	2025	12
Routine evaluation and treatment of unexplained menorrhagia: do we consider haemostatic disorders? H.M. Knol, D.H. Bogchelman, Hanneke C. Kluin‐Nelemans, European Journal of Obstetrics & Gynecology and Reproductive Biology Postpartum HemorrhageGynecologyHemostasisUnexplained MenorrhagiaEmergency Medicine	2010	11

Page 1